Elpida Therapeutics, Catalent Partner for Late-Phase AAV Manufacturing

WatersWaters Corporation stock (US9418481035): Analytical instruments leader for US life sciences - AD HOC NEWS

BioPharma DiveFDA’s leadership void leaves biotech with renewed ‘uncertainty’

Endpoints NewsAbeona pivots to T cells; AstraZeneca's rare disease drug passes Phase 3

BioPharma DiveLilly data point to ‘maintenance’ strategies for GLP-1 weight loss

FierceBiotechHumacyte cuts spending, staff as it seeks to boost sluggish sales for its off-the-shelf artery implant

FierceBiotechWith $1B Novo deal and diabetes ambitions undimmed, Lexicon is in ‘good shape to go crazy’

BioWorldNvision secures $55 million, with backing from Abbott

BioWorldAppointments and advancements for May 13, 2026

BioWorldFinancings for May 13, 2026

BioWorldIn the clinic for May 13, 2026

BioWorldOther news to note for May 13, 2026

BioWorldRegulatory actions for May 13, 2026